𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Viral Prophylaxis in Organ Transplant Patients

✍ Scribed by Michelle Slifkin; Shira Doron; David R. Snydman

Publisher
John Wiley and Sons
Year
2005
Weight
8 KB
Volume
36
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alternative EBNA1 expression in organ tr
Alternative EBNA1 expression in organ transplant patients
✍ Malin Å.M. Berggren; Åsa Isaksson; Ulrica Larsson; Folke Nilsson; Ulla Nyström; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

In order to identify patients at risk for developing post-transplant lymphoproliferative disease (PTLD), a sensitive nested RT-PCR method for detection of EBNA1 gene expression in peripheral blood cells was used. EBNA1 expression in peripheral blood samples from 60 organ recipients was analyzed and

Analysis of cytomegalovirus DNA polymera
Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis
✍ Guy Boivin; Nathalie Goyette; Christian Gilbert; Emma Covington 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

## Abstract We previously reported the absence of CMV __UL97__ (kinase) gene resistance mutations up to 12 months post‐transplant following 100 days of valganciclovir prophylaxis, and a low incidence of resistance mutations following 100 days of oral ganciclovir prophylaxis in a prospective multice

Cytomegalovirus prophylaxis with valganc
Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients
✍ Hugo Wéclawiak; Nassim Kamar; Catherine Mengelle; Joëlle Guitard; Laure Esposito 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The aims of this prospective, open‐label, single‐center pilot study were to assess the efficacy and safety of human cytomegalovirus (HCMV) prophylaxis using valganciclovir in HCMV‐ seropositive kidney‐transplant patients to prevent HCMV infection and disease. Fifty‐one HCMV seropositive

Antifungal prophylaxis in liver transpla
Antifungal prophylaxis in liver transplant recipients
✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse